Additional Proxy Soliciting Materials (definitive) (defa14a)
April 14 2020 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section
14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
☑
|
Filed by the Registrant
|
☐
|
Filed by a Party other
than the Registrant
|
|
CHECK THE APPROPRIATE BOX:
|
☐
|
|
Preliminary Proxy Statement
|
☐
|
|
Confidential, For Use of the Commission Only
(as permitted by Rule 14a-6(e)(2))
|
☐
|
|
Definitive Proxy Statement
|
☑
|
|
Definitive Additional Materials
|
☐
|
|
Soliciting Material Under Rule
14a-12
|
BioMarin Pharmaceutical Inc.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy
Statement, if Other Than the Registrant)
PAYMENT OF FILING FEE (CHECK THE APPROPRIATE
BOX):
|
☑
|
|
No fee
required.
|
☐
|
|
Fee computed on table below per Exchange Act Rules
14a-6(i)(1) and 0-11.
|
|
|
|
1)
Title of each class of securities to which transaction
applies:
|
|
|
|
2)
Aggregate number of securities to which transaction applies:
|
|
|
|
3)
Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
4)
Proposed maximum aggregate value of transaction:
|
|
|
|
5) Total fee paid:
|
☐
|
|
Fee paid previously with
preliminary materials:
|
☐
|
|
Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the form or schedule and the
date of its filing.
|
|
|
|
1)
Amount previously paid:
|
|
|
|
2)
Form, Schedule or Registration Statement No.:
|
|
|
|
3)
Filing Party:
|
|
|
|
4) Date
Filed:
|
*** Exercise Your Right to Vote ***
Important Notice
Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on May 27, 2020
BIOMARIN PHARMACEUTICAL INC.
BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA 94949
ATTN: G. ERIC DAVIS, EVP & GENERAL
COUNSEL
Meeting Information
|
|
Meeting Type: Annual Meeting
|
|
|
For holders as of: March 30, 2020
|
|
|
Date: May 27, 2020 Time: 9:00 AM PDT
|
|
|
Location:
|
www.virtualshareholdermeeting.com/BMRN2020
|
|
|
|
*
|
|
|
|
|
|
|
|
|
|
|
|
|
|
You are receiving this communication because you hold shares in the above named company.
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the
proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side of this notice to obtain proxy
materials and voting instructions.
|
— Before You Vote —
How to Access the Proxy Materials
|
Proxy Materials Available to VIEW or RECEIVE:
|
|
|
1. Notice & Proxy Statement 2. Form 10-K 3. CEO Stockholder
Letter
|
|
|
How to View Online:
|
|
|
|
|
Have the information that is printed in the box marked by the arrow → XXXX XXXX XXXX XXXX (located on the following page) and visit: www.proxyvote.com.
|
|
|
How to Request and Receive a PAPER or E-MAIL Copy:
|
|
|
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please
choose one of the following methods to make your request:
|
|
|
|
1) BY INTERNET:
|
www.proxyvote.com
|
|
|
|
2) BY TELEPHONE:
|
1-800-579-1639
|
|
|
|
3) BY E-MAIL*:
|
sendmaterial@proxyvote.com
|
|
|
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the
box marked by the arrow → XXXX XXXX XXXX XXXX
(located on the following page) in the subject line.
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before
May 13, 2020 to facilitate timely delivery.
|
|
— How To Vote —
Please Choose One of the Following Voting Methods
|
Vote In Person: Many stockholder meetings have attendance requirements including,
but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these
shares.
|
|
|
Vote By Internet: To vote now by Internet, go to www.proxyvote.com.
Have the information that is printed in the box marked by the arrow → XXXX XXXX XXXX XXXX available and follow the instructions.
|
|
|
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
|
|
Voting items
|
The Board of Directors recommends you vote
FOR the following:
|
1.
|
|
Election of Directors
|
|
|
Nominees
|
01
|
Jean-Jacques Bienaimé
|
|
02
|
Elizabeth M. Anderson
|
|
03
|
Willard Dere
|
|
04
|
Michael Grey
|
|
05
|
Elaine J. Heron
|
06
|
Robert J. Hombach
|
|
07
|
V. Bryan Lawlis
|
|
08
|
Richard A. Meier
|
|
09
|
David E.I. Pyott
|
|
10
|
Dennis J. Slamon
|
The Board of Directors recommends you vote FOR proposals 2 and 3.
2
|
To ratify the selection of KPMG LLP as the independent registered public accounting firm for BioMarin for the fiscal year ending December 31, 2020.
|
|
|
3
|
To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.
|
NOTE: Your proxy holder will
also vote on any other business properly brought before the Annual Meeting.
*We are monitoring the situation regarding
the coronavirus or COVID-19, and are planning for the possibility that the Annual Meeting may be held in person at the
Companys offices in the Morning Glory Conference Room, 750 Lindaro Street, San Rafael, CA 94901. If we take this step, we
will announce the decision to do so in advance, and details on how to attend in person will be available at
https://investors.biomarin.com.
|
|
|
|
|
|
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024